Here are your complete, high-yield MBBS biochemistry revision notes across all 6 topics:
📚 MBBS Biochemistry - High-Yield Revision Notes
1. ENZYMOLOGY
Key Concepts
What is an enzyme?
- Biological catalysts (mostly proteins; ribozymes are RNA enzymes)
- Lower the activation energy of a reaction
- Not consumed in the reaction; highly specific (substrate specificity)
Active site - where substrate binds; made of a few key amino acid residues
Enzyme Kinetics (Michaelis-Menten)
| Term | Meaning |
|---|
| Km | Substrate concentration at half Vmax; measure of enzyme-substrate affinity (LOW Km = HIGH affinity) |
| Vmax | Maximum reaction velocity when enzyme is saturated |
| Kcat | Turnover number - reactions per second per enzyme molecule |
- Lineweaver-Burk plot = double reciprocal (1/V vs 1/[S]); x-intercept = -1/Km, y-intercept = 1/Vmax
Enzyme Inhibition
| Type | Km | Vmax | Antidote example |
|---|
| Competitive | Increases | Unchanged | Ethanol (methanol poisoning) |
| Non-competitive | Unchanged | Decreases | - |
| Uncompetitive | Decreases | Decreases | - |
| Irreversible | - | Decreases permanently | Pralidoxime (organophosphate) |
MBBS tip: Competitive inhibitors compete with substrate for the active site; can be overcome by increasing substrate concentration. Non-competitive bind allosteric sites.
Regulation of Enzyme Activity
- Allosteric regulation - effector binds non-active site; sigmoidal kinetics (not Michaelis-Menten)
- Covalent modification - phosphorylation (kinases) / dephosphorylation (phosphatases)
- Zymogen activation - inactive precursors (e.g. trypsinogen → trypsin, pepsinogen → pepsin)
- Feedback inhibition - end product inhibits an early enzyme in the pathway
Isoenzymes (High-yield for MBBS)
| Isoenzyme | Subunits | Clinical Use |
|---|
| LDH-1 (H4) | Heart | ↑ in MI (heart and RBC) |
| LDH-5 (M4) | Liver/skeletal muscle | ↑ in liver disease |
| CK-MB | Heart | ↑ in MI |
| CK-MM | Skeletal muscle | ↑ in muscle damage |
| ALP isoforms | Bone, liver, intestine | ↑ in Paget's (bone), cholestasis (liver) |
Cofactors & Coenzymes
| Vitamin | Coenzyme | Enzyme/Reaction |
|---|
| B1 (Thiamine) | TPP | Pyruvate dehydrogenase, α-KG DH, Transketolase |
| B2 (Riboflavin) | FAD/FMN | Electron transfer in ETC |
| B3 (Niacin) | NAD+/NADP+ | Oxidation-reduction reactions (Krebs, glycolysis) |
| B5 (Pantothenate) | CoA | Acyl group transfer |
| B6 (Pyridoxine) | PLP | Transamination, decarboxylation |
| B7 (Biotin) | Biotin | Carboxylation reactions (ACC, pyruvate carboxylase) |
| B9 (Folate) | THF | One-carbon transfer |
| B12 | Cobalamin | Methylmalonyl-CoA mutase, methionine synthase |
2. MOLECULAR BIOLOGY
DNA Structure
- Double helix; antiparallel strands; base pairing: A=T (2 H-bonds), G≡C (3 H-bonds)
- B-DNA is physiological form; right-handed helix, 10 bp per turn
- Chargaff's rule: %A = %T; %G = %C
DNA Replication
- Semi-conservative (each new DNA has one old + one new strand)
- Occurs in S phase of cell cycle
- Origin of replication - starts at AUG (multiple in eukaryotes, one in prokaryotes)
Key Enzymes:
| Enzyme | Function |
|---|
| Helicase | Unwinds double helix |
| Primase | Synthesizes RNA primer |
| DNA Pol III | Main replication enzyme (prokaryotes); adds nucleotides 5'→3' |
| DNA Pol I | Removes RNA primers, fills gaps |
| DNA Ligase | Joins Okazaki fragments |
| Topoisomerase | Relieves supercoiling (target of fluoroquinolones) |
| Telomerase | Adds repeats to chromosome ends (uses RNA template) |
- Leading strand - continuous synthesis (5'→3')
- Lagging strand - discontinuous Okazaki fragments
Transcription (DNA → RNA)
- RNA Polymerase II - makes mRNA in eukaryotes
- Prokaryote RNA Pol - one enzyme for all RNA types
- Promoter - TATA box (eukaryotes), Pribnow box (prokaryotes)
- mRNA Processing (eukaryotes): 5' cap (7-methylguanosine) + poly-A tail + splicing of introns
Introns = "In the trash" (removed); Exons = "Expressed"
Translation (mRNA → Protein)
- Occurs on ribosomes: 80S (60S + 40S) eukaryotes; 70S (50S + 30S) prokaryotes
- Codons on mRNA; Anticodons on tRNA
- Start codon: AUG (methionine); Stop codons: UAA, UAG, UGA ("U Are Away", "U Are Gone", "U Go Away")
- Stages: Initiation → Elongation → Termination
Antibiotic targets on prokaryotic ribosomes:
| Drug | Target | Mnemonic |
|---|
| Aminoglycosides, Tetracyclines | 30S | "Buy AT 30" |
| Chloramphenicol, Clindamycin, Erythromycin | 50S | "CEL at 50" |
Mutations
| Type | Description | Example |
|---|
| Silent | Same amino acid (wobble position) | Often C→T at 3rd base |
| Missense | Different amino acid | Sickle cell (Glu→Val) |
| Nonsense | Premature stop codon | Beta-thalassemia |
| Frameshift | Insertion/deletion; shifts reading frame | Duchenne MD |
DNA Repair
- Nucleotide excision repair - fixes bulky adducts (UV damage, xeroderma pigmentosum)
- Base excision repair - fixes small base damage (deamination)
- Mismatch repair - corrects replication errors (defect → HNPCC/Lynch syndrome)
- Double-strand break - homologous recombination (accurate) or NHEJ (error-prone)
3. CELLS
Cell Organelles & Functions
| Organelle | Key Functions |
|---|
| Nucleus | DNA storage, transcription |
| Nucleolus | rRNA synthesis, ribosome assembly |
| Rough ER | Synthesis of secretory & membrane proteins |
| Smooth ER | Lipid synthesis, drug detoxification, Ca2+ storage |
| Golgi apparatus | Post-translational modification, protein sorting/packaging |
| Mitochondria | ATP production (Krebs, ETC, β-oxidation); has own DNA (maternal inheritance) |
| Lysosomes | Intracellular digestion (acid hydrolases, pH ~5) |
| Peroxisomes | β-oxidation of very long chain fatty acids; bile acid synthesis |
| Cytoskeleton | Cell shape, movement, division |
Cytoskeleton Components
| Structure | Protein | Function |
|---|
| Microfilaments | Actin | Cell movement, cytokinesis |
| Intermediate filaments | Keratin, vimentin, desmin, GFAP | Structural support |
| Microtubules | Tubulin (α/β) | Mitotic spindle, cilia, axonal transport |
Cilia - 9+2 arrangement of microtubules; dynein = motor protein. Dynein defect → Kartagener syndrome
Cell Membrane
- Fluid mosaic model: phospholipid bilayer with embedded proteins
- Hydrophilic heads face outward; hydrophobic tails face inward
- Cholesterol - stabilizes membrane fluidity
- Glycoproteins/glycolipids - cell recognition, blood group antigens
Cell Cycle
G1 → S (DNA synthesis) → G2 → M (Mitosis)
↑ Cyclin-CDK checkpoints
- G1/S checkpoint - regulated by cyclin D/CDK4,6 → phosphorylates Rb → releases E2F
- G2/M checkpoint - cyclin B/CDK1
- p53 - "guardian of the genome"; activates p21 (CDK inhibitor) → cell cycle arrest
- Rb gene - tumor suppressor; mutation → retinoblastoma, osteosarcoma
Cell Signaling (important types)
| Receptor Type | Ligands | Mechanism |
|---|
| GPCR | Epinephrine, glucagon, TSH | Adenylyl cyclase → cAMP → PKA |
| RTK | Insulin, growth factors | Autophosphorylation → Ras → MAPK |
| Nuclear receptors | Steroids, thyroid hormone | Directly bind DNA response elements |
| Ion channels | ACh (nicotinic) | Direct ion flow |
4. CARBOHYDRATES
Glycolysis (Cytoplasm)
- Glucose (6C) → 2 Pyruvate (3C)
- Net yield: 2 ATP + 2 NADH (anaerobic: 2 lactate)
- Key regulatory enzymes:
- Hexokinase/Glucokinase - step 1 (Glucokinase in liver: high Km, induced by insulin)
- Phosphofructokinase-1 (PFK-1) - rate-limiting step; inhibited by ATP, citrate; activated by AMP, fructose-2,6-bisphosphate
- Pyruvate kinase - final step
Pyruvate Dehydrogenase Complex (PDC)
- Pyruvate → Acetyl-CoA (irreversible, in mitochondria)
- Requires: B1 (TPP), B2 (FAD), B3 (NAD+), B5 (CoA), Lipoic acid
- Mnemonic: "Tender Loving Care For Nerves" (TPP, Lipoate, CoA, FAD, NAD+)
- PDC deficiency → lactic acidosis, neurological problems
TCA Cycle (Krebs Cycle) - Mitochondria
- Acetyl-CoA (2C) + OAA (4C) → Citrate (6C) → ... → OAA
- Yield per turn: 3 NADH + 1 FADH2 + 1 GTP + 2 CO2
- Rate-limiting enzyme: Isocitrate dehydrogenase
- Key enzymes: Citrate synthase, Isocitrate DH, α-KG DH, Succinate DH (only membrane-bound; FADH2)
Electron Transport Chain (ETC) + Oxidative Phosphorylation
- Located in inner mitochondrial membrane
- Complex I (NADH → CoQ), II (FADH2 → CoQ), III (CoQ → Cyt c), IV (Cyt c → O2)
- ATP synthase (Complex V) - uses proton gradient (chemiosmosis)
- Yield: NADH = 2.5 ATP; FADH2 = 1.5 ATP
- Total glucose oxidation: ~30-32 ATP
ETC Inhibitors:
| Agent | Blocks |
|---|
| Rotenone | Complex I |
| Antimycin A | Complex III |
| Cyanide, CO | Complex IV |
| Oligomycin | ATP synthase |
| Dinitrophenol | Uncoupler (↑ heat, ↓ ATP) |
Gluconeogenesis
- Glucose synthesis from non-carbohydrate precursors (lactate, glycerol, amino acids - especially alanine)
- Primarily in liver (also kidney in fasting)
- Bypasses 3 irreversible glycolysis steps using:
- Pyruvate carboxylase → OAA (requires biotin)
- PEPCK → PEP
- Fructose-1,6-bisphosphatase
- Glucose-6-phosphatase (liver only)
Glycogen Metabolism
| Process | Enzyme | Regulated by |
|---|
| Synthesis | Glycogen synthase | Insulin (activates), glucagon/epinephrine (inactivate) |
| Breakdown | Glycogen phosphorylase | Glucagon, epinephrine (activate) |
Glycogen storage diseases:
| Disease | Enzyme defect | Organ | Key feature |
|---|
| Von Gierke (Ia) | Glucose-6-phosphatase | Liver, kidney | Fasting hypoglycemia, hepatomegaly |
| Pompe (II) | Acid maltase (α-1,4-glucosidase) | Heart, muscle | Cardiomegaly, hypotonia |
| Cori (III) | Debranching enzyme | Liver, muscle | Mild Von Gierke-like |
| McArdle (V) | Muscle phosphorylase | Muscle | Cramps, no lactate rise with exercise |
HMP Shunt (Pentose Phosphate Pathway)
- In cytoplasm; no ATP production
- Products: NADPH (for anabolic reactions and oxidative burst), Ribose-5-phosphate (nucleotide synthesis)
- Rate-limiting: Glucose-6-phosphate dehydrogenase (G6PD)
- G6PD deficiency → hemolytic anemia with oxidant stress (primaquine, fava beans)
Blood Glucose Regulation
| Hormone | Blood glucose | Key action |
|---|
| Insulin | ↓ | ↑ GLUT4 in muscle/fat; ↑ glycolysis, glycogenesis; ↓ gluconeogenesis |
| Glucagon | ↑ | ↑ glycogenolysis, gluconeogenesis (liver only) |
| Epinephrine | ↑ | ↑ glycogenolysis (muscle + liver) |
| Cortisol | ↑ | ↑ gluconeogenesis; insulin resistance |
5. AMINO ACIDS & METABOLISM
Essential Amino Acids (10)
"PVT TIM HaLL" - Phenylalanine, Valine, Tryptophan, Threonine, Isoleucine, Methionine, Histidine, Arginine (conditionally), Leucine, Lysine
Amino Acid Structure
- All have: α-amino group, α-carboxyl group, H, and R (side chain)
- Amphoteric - act as acid and base (zwitterion at physiological pH)
- At pI (isoelectric point): net charge = 0
Transamination
- Transfer of amino group from amino acid to α-ketoacid
- Key enzyme: Aminotransferases (require PLP/B6)
- ALT (alanine transaminase) - liver-specific
- AST (aspartate transaminase) - liver + heart
Urea Cycle (liver mitochondria + cytoplasm)
Ammonia is toxic → converted to urea for excretion
Steps: NH3 + CO2 → Carbamoyl phosphate → Citrulline → Argininosuccinate → Arginine → Urea + Ornithine
Rate-limiting: Carbamoyl phosphate synthetase I (CPS-I)
- Activated by N-acetylglutamate (NAG)
- NAG synthesis activated by arginine
Urea cycle disorders: hyperammonemia → encephalopathy, intellectual disability
| Enzyme defect | Accumulates |
|---|
| CPS-I | Ammonia only |
| OTC (ornithine transcarbamylase) | Ammonia + orotic acid (most common X-linked) |
| Arginosuccinate synthetase (Citrullinemia) | Citrulline |
| Arginosuccinate lyase | Argininosuccinate |
| Arginase | Arginine |
Key Amino Acid Disorders
| Disorder | Enzyme Defect | Key Findings |
|---|
| PKU | Phenylalanine hydroxylase (or BH4) | Musty odor, intellectual disability, fair skin, eczema |
| Alkaptonuria | Homogentisate oxidase | Dark urine, ochronosis, arthritis |
| Maple Syrup Urine Disease | Branched-chain α-keto acid DH | Sweet urine, neurological damage; restrict Leu, Ile, Val |
| Homocystinuria | Cystathionine synthase (or B12/folate deficiency) | Lens subluxation (down), Marfanoid, DVT, intellectual disability |
| Albinism | Tyrosinase | No melanin, photosensitivity |
| Hartnup disease | Tryptophan transporter (neutral amino acids) | Pellagra-like rash, ataxia |
One-Carbon Metabolism
- Folate (THF) + B12 carry one-carbon units
- Methionine synthase: Homocysteine + CH3-THF → Methionine + THF (needs B12)
- Folate deficiency → megaloblastic anemia, neural tube defects
- B12 deficiency → megaloblastic anemia + subacute combined degeneration of spinal cord
- Methylmalonic acid ↑ in B12 deficiency only (distinguishes from folate deficiency)
Heme Synthesis & Porphyrias
- ALA synthase (rate-limiting; mitochondria) - requires B6
- Porphobilinogen → Uroporphyrinogen → Coproporphyrinogen → Heme
| Porphyria | Enzyme defect | Key features |
|---|
| AIP (Acute Intermittent) | PBG deaminase | 5 Ps: Pain (abdomen), Port-wine urine, Polyneuropathy, Psychological, Precipitated by drugs |
| PCT (Porphyria Cutanea Tarda) | Uroporphyrinogen decarboxylase | Photosensitive blistering, most common porphyria |
| Lead poisoning | ALA dehydratase + Ferrochelatase | Basophilic stippling, ↑ ALA, ↑ ZnPP |
6. LIPIDS
Fatty Acid Synthesis (Cytoplasm)
- Glucose → Acetyl-CoA → Malonyl-CoA → Palmitate (16C)
- Rate-limiting enzyme: Acetyl-CoA Carboxylase (ACC); requires biotin
- Activated by insulin and citrate; inhibited by glucagon, epinephrine, palmitoyl-CoA
- Fatty acid synthase (FAS) is a multifunctional enzyme
Beta-Oxidation (Mitochondria)
- Breaks down fatty acids → Acetyl-CoA
- Entry requires carnitine shuttle (long-chain FA cannot enter directly)
- Carnitine palmitoyltransferase I (CPT-I) - rate-limiting; inhibited by malonyl-CoA
- Each cycle removes 2 carbons as Acetyl-CoA
- Yield per cycle: 1 NADH + 1 FADH2 + 1 Acetyl-CoA
Odd-chain FA → final product is propionyl-CoA → methylmalonyl-CoA → succinyl-CoA (requires B12)
Ketone Bodies
- Produced in liver mitochondria during prolonged fasting, starvation, DKA
- Acetoacetate, β-hydroxybutyrate, acetone
- Cannot be used by liver (lacks thiophorase/succinyl-CoA acetoacetyl transferase)
- Used by brain, heart, skeletal muscle, kidney cortex
In DKA: ketones ↑, metabolic acidosis, fruity breath (acetone)
Cholesterol Metabolism
- Synthesized in liver from Acetyl-CoA (cytoplasm)
- Rate-limiting enzyme: HMG-CoA reductase (target of statins)
- Cholesterol → bile acids (bile salt synthesis), steroid hormones, Vitamin D, cell membranes
Lipoproteins
| Lipoprotein | Made in | Carries mainly | Key protein |
|---|
| Chylomicrons | Intestine | Dietary TGs | ApoB-48 |
| VLDL | Liver | Endogenous TGs | ApoB-100 |
| IDL | From VLDL | TGs + Cholesterol | ApoB-100, ApoE |
| LDL | From IDL | Cholesterol ("bad") | ApoB-100 |
| HDL | Liver/intestine | Reverse cholesterol transport | ApoA-I |
Key Apoproteins:
- ApoC-II - activates lipoprotein lipase (LPL)
- ApoE - receptor binding; ApoE4 → ↑ Alzheimer's risk
- ApoB-100 - LDL receptor binding
Phospholipids & Sphingolipids
| Lipid | Key role |
|---|
| Phosphatidylcholine (lecithin) | Major membrane component, lung surfactant |
| Phosphatidylinositol | Second messenger precursor (DAG, IP3) |
| Sphingomyelin | Myelin sheath |
| Cerebroside | Brain glycolipids |
| Gangliosides | Neuronal signaling |
Sphingolipidoses
| Disease | Enzyme Defect | Accumulates | Key Feature |
|---|
| Gaucher's | Glucocerebrosidase | Glucocerebroside | Hepatosplenomegaly, "Crinkled paper" cells, bone pain; most common |
| Niemann-Pick | Sphingomyelinase | Sphingomyelin | HSM, cherry-red macula, "foamy" cells |
| Tay-Sachs | Hexosaminidase A | GM2 ganglioside | Cherry-red macula, NO hepatosplenomegaly |
| Fabry's | α-Galactosidase A | Globotriaosylceramide | Angiokeratomas, renal failure, X-linked |
| Krabbe's | Galactocerebrosidase | Galactocerebroside | Peripheral neuropathy, globoid cells |
| Metachromatic leukodystrophy | Arylsulfatase A | Cerebroside sulfate | Demyelination, ataxia |
Mnemonic for Tay-Sachs vs Niemann-Pick: Tay-Sachs = No Spleen; Niemann-Pick = Pick up the spleen
Quick-Reference: High-Yield MBBS Biochemistry Facts
| Topic | Most Asked |
|---|
| Enzymology | Km/Vmax, competitive vs non-competitive inhibition, isoenzymes in MI |
| Molecular Biology | DNA replication enzymes, antibiotic ribosome targets, mutations |
| Cells | Organelle functions, cytoskeleton disorders, cell cycle checkpoints |
| Carbohydrates | PFK-1 regulation, PDC cofactors, glycogen storage diseases, ETC inhibitors |
| Amino Acids | PKU, homocystinuria, urea cycle (OTC deficiency), porphyrias |
| Lipids | ACC (rate-limiting synthesis), CPT-1 (rate-limiting β-oxidation), statins, sphingolipidoses |
These notes cover the highest-yield examinable material for MBBS university biochemistry. Focus especially on:
- Enzyme kinetics graphs (Lineweaver-Burk)
- Glycogen storage diseases and sphingolipidoses (frequently asked as clinical vignettes)
- Urea cycle enzyme defects and distinguishing features
- Vitamin-coenzyme pairings and their deficiency diseases
- Isoenzymes in disease (LDH, CK, ALP)